Navigation Links
Medipacs Chosen to Present at Invest Southwest Capital Conference
Date:11/19/2008

TUCSON, Ariz., Nov. 19 /PRNewswire/ -- Medipacs, Inc., a Tucson based drug delivery device company announces today the company has been selected to present at the Invest Southwest Capital Conference to be held in Scottsdale, AZ on December 10 and 11, 2008.

One of only 12 companies to present at the conference, Medipacs was selected from 84 submissions in a variety of high-tech fields. "Generally speaking, (the businesses) have to be highly scalable and highly defensible" said Dave Bittner, this year's conference chairman.

Medipacs was founded in 2004 by Mark Banister, a career entrepreneur and was awarded several grants from the National Science Foundation and Science Foundation of Arizona which helped advance fundamentally new polymer science to the point of attracting investor attention. Medipacs' novel polymer gel expands to multiples of its original size. This large expansion ratio occurs precisely and rapidly which enables a variety of practical, low cost drug delivery devices to be used for administering small volume Parenteral (SVP) drugs. According to recent studies, SVP drugs are often implicated in drug delivery errors that extend hospital stays and increase variable costs and Medipacs devices are aimed at reducing many of these errors with its novel delivery systems.

Since June 2007, the company has raised $1.7M from Mesa Verde Ventures, a seed stage venture firm specializing in medical device start-ups in San Diego, CA, and from angel investors in Tucson, San Diego and Washington DC. Mark McWilliams, CEO of Medipacs, has been the co-founder of two drug delivery device companies which brought new drug delivery technologies to market. He has also developed devices and systems serving other medical fields.

Bill Bloom, V.P. Engineering, a Caltech graduate that has worked in the medical device field for over 35 years and who developed insulin pumps for Alfred Mann at Mini-Med in the 1980's and then at Siemens leads the engineering effort and said: "Medipacs has developed the first truly unique infusion pump mechanism I have seen in the last 30 years and it is the most versatile, low cost mechanism for accurately metering drugs which I have ever seen or been part of commercializing. Medipacs' technology can disrupt and obsolete existing methods for delivery of SVP drugs."

About Medipacs

Medipacs, Inc. is a Tucson based drug delivery device company with expertise in hydro gel polymers. It is developing advanced infusion technologies and is now focused on its first commercial application, a programmable disposable infusion device called a Mini-Infuser(TM). The company is located at the Arizona Center for Innovation. Please contact: Mark McWilliams 858-227-0569 MarkMcWilliams@mediapcs.com

About the Invest Southwest Capital Conference

Invest Southwest has been connecting entrepreneurs and investors in Arizona and the Southwest for over 15 years. Companies that have presented at past Invest Southwest conferences include Ventana Medical, Flypaper, NetPro, Vivid Semiconductor, and AutoXray. Companies submitting to present seek between $250,000 and $5MM in capital. For more information about the conference, with title sponsor The Miller Group, visit http://www.investsouthwest.org.


'/>"/>
SOURCE Medipacs, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Medipacs Appoints Advisory Board Members
2. Medipacs Initial Financing
3. Elizabeth, NJ Chosen for Alliance/Merck Ciencia (Science) Hispanic Scholars Program
4. EDS Chosen to Manage Combat Veteran Call Center for Department of Veterans Affairs
5. The Initiative for Elder Planning Studies Has Chosen to Include The Estate Vault as Part of Their Membership Offering
6. Syndicoms Collaborative Web Platform Chosen to Facilitate Clinical Trials for Lumbar Disc Device from Aesculap Implant Systems
7. Linkwell Corporations Skin Disinfectant Product Chosen for 2008 Beijing Olympic Games
8. Local Families Chosen for Ambassador Role for 2008 March for Babies
9. Ten Finalists Chosen for 2007 Hutch Award
10. Vanderbilt Medical Center chosen as Evidence-based Practice Center
11. WaveMark, Inc. is Chosen by UMass Memorial Medical Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... ... May 04, 2016 , ... ... of commercial real estate proudly announced that its service-based charitable program, Olshan Outreach, ... members portfolio-wide will continue Olshan Properties’ annual philanthropic tradition in 2016 with the ...
(Date:5/4/2016)... Columbia, MD (PRWEB) , ... May 04, 2016 ... ... Wound, Ostomy and Continence Nurses (WOCN) Society™ and Canadian Association for Enterostomal ... matchmaking, event promotion, time saving and planning tools to attendees and exhibitors for ...
(Date:5/4/2016)... ... 2016 , ... All-Star Insurance of Northeast TX has announced ... their local community. The agency pledges to select a new beneficiary every 60 ... bring awareness to important local causes with fundraising and other support, by forming ...
(Date:5/4/2016)... Island (PRWEB) , ... May 04, 2016 , ... ... in April 2016. SS&A teamed up with one of the top website design ... information portal contains informative legal articles related to the law firm's main practice ...
(Date:5/4/2016)... , ... May 04, 2016 , ... ... foundational nutrients that supports cellular and metabolic health. This synergistic combination of omega-3 ... free-form curcumin, along with 150 mg of reduced glutathione and 200 mg of ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... May 4, 2016 Valeritas Holdings, ... an alternative public offering (APO). This was accomplished via ... Valeritas, Inc. and a private placement of approximately 5 ... per share. Under the terms of the ... Valeritas Holdings, Inc. will trade on the OTC Markets ...
(Date:5/4/2016)... , May 4, 2016 ... addition of the  "Global Actinic Keratosis Market ... to their offering.       (Logo: ... Keratosis Market and Competitive Landscape Highlights 2016, ... products, Actinic Keratosis epidemiology, Actinic Keratosis market ...
(Date:5/3/2016)... , May 4, 2016 Research ... "Global Cancer Stem Cell Therapy Market Outlook 2020" ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,Recombinant technology has improved significantly ... expected to be developed in coming years. Many cancer ... Cancer stem cell therapies are also expected to be ...
Breaking Medicine Technology: